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The generation of new neurons in the adult dentate gyrus has functional implications
for hippocampal formation. Reduced hippocampal neurogenesis has been described in
various animal models of hippocampal dysfunction such as dementia and depression,
which are both common non-motor-symptoms of Parkinson’s disease (PD). As dopamine
plays an important role in regulating precursor cell proliferation, the loss of dopaminergic
neurons in the substantia nigra (SN) in PD may be related to the reduced neurogenesis
observed in the neurogenic regions of the adult brain: subventricular zone (SVZ)
and dentate gyrus (DG). Here we examined adult hippocampal neurogenesis in the
Pitx3-mutant mouse model of PD (aphakiamice), which phenotypically shows a selective
embryonic degeneration of dopamine neurons within the SN and to a smaller extent in
the ventral tegmental area (VTA). Proliferating cells were labeled with BrdU in aphakia
mice and healthy controls from 3 to 42 weeks of age. Three weeks old mutant mice
showed an 18% reduction of proliferating cells in the DG and of 26% in the SVZ. Not only
proliferation but also the number of new neurons was impaired in young aphakia mice
resulting in 33% less newborn cells 4 weeks after BrdU-labeling. Remarkably, however,
the decline in the number of proliferating cells in the neurogenic regions vanished
in older animals (8–42 weeks) indicating that aging masks the effect of dopamine
depletion on adult neurogenesis. Region specific reduction in precursor cells proliferation
correlated with the extent of dopaminergic degeneration in mesencephalic subregions
(VTA and SN), which supports the theory of age- and region-dependent regulatory
effects of dopaminergic projections. Physiological stimulation of adult neurogenesis by
physical activity (wheel running) almost doubled the number of proliferating cells in
the dentate gyrus of 8 weeks old aphakia mice to a number comparable to that of
wild-type mice, abolishing the slight reduction of baseline neurogenesis at this age. The
described age-dependent susceptibility of adult neurogenesis to PD-like dopaminergic
degeneration and its responsiveness to physical activity might have implications for the
understanding of the pathophysiology and treatment of non-motor symptoms in PD.
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INTRODUCTION
Structural change of neuronal networks in the brain is an
important mechanism for learning and memory (Shors et al.,
2001). Generation and degeneration of synaptic connections as
well as the addition of new neurons in the dentate gyrus and
olfactory bulb maintaining cell turnover in these regions provide
optimal network function via neuronal plasticity. Particularly
neurogenesis in the adult brain as a maximal way of cellular
plasticity has been investigated in various animal models of
neuropsychiatric diseases as well as the human brain. Impaired
neurogenesis in the dentate gyrus of the hippocampus has been
suggested to play an important role in the pathophysiology
of depression and cognitive impairment (Feng et al., 2001;
Kempermann and Kronenberg, 2003; Snyder et al., 2011; Hill
et al., 2015; Schoenfeld and Cameron, 2015). Taken together,
adult neurogenesis is a physiological mechanism with functional
relevance for structures that benefit from an increased cell
turnover: the dentate gyrus of the hippocampus and the olfactory
bulb.
Depression, cognitive impairment and hyposmia are common
non-motor symptoms of Parkinson’s disease (PD; Reichmann
et al., 2016), a neurodegenerative disease that is characterized
by the loss of dopaminergic neurons in the mesencephalon. As
dopamine plays an important role in regulating neurogenesis
during embryonic development (Diaz et al., 1997), it has
already been suggested that alterations of dopamine level in
PD might also affect adult neurogenesis in the neurogenic
regions and thereby promote the development of depression,
dementia and hyposmia (Marxreiter et al., 2013b). Hoeglinger
et al. were the first to investigate adult neurogenesis after acute
degeneration of the mesencephalic dopaminergic system using
the neurotoxins MPTP and 6-hydroxydopamine (6-OHDA),
respectively (Hoglinger et al., 2004). They observed significant
reduction of cell proliferation in the subgranular zone of the
dentate gyrus (SGZ) and the subventricular zone (SVZ), a
region containing stem- and precursor cells that give rise to
newborn neurons of the olfactory bulb (OB). Neural stem-
and progenitor cells of the SVZ and SGZ receive dopaminergic
input frommesencephalic neurons (Hoglinger et al., 2004, 2014).
Dopaminergic neurons of the mesencephalon are located in the
substantia nigra pars compacta (SNc) also called A9 region and
the ventral tegmental area (VTA) called A10 region (German
and Manaye, 1993). While A9 cells predominantly innervate
the striatum and the adjacent dorsal SVZ, the ventral SVZ
receives dopaminergic input from A10 cells, and the SGZ of the
hippocampus is innervated homogenously by A9 and A10 cells
(Hoglinger et al., 2014).
A9 and A10 dopaminergic neurons also differ in the
expression of Pitx3, a transcription factor with neuroprotective
properties (Hwang et al., 2003; Nunes et al., 2003; van den
Munckhof et al., 2003). The so called aphakia mice lack the
expression of Pitx3 due to a homozygote mutation in the Pitx3-
gene resulting in a selective degeneration of mesencephalic
dopaminergic neurons during embryonic development (Hwang
et al., 2003; van den Munckhof et al., 2003; Smidt et al.,
2004). This selective degeneration has been used as a genetic
animal model of Parkinson’s disease in several studies showing
typical levodopa responsive motor deficits (Hwang et al., 2005;
Le et al., 2015). Moreover, Pitx3 mutant mice also exhibit
typical non-motor symptoms of PD like memory dysfunction
and depression-related behavior indicating a hippocampal
dysfunction (Ardayfio et al., 2008; Kim et al., 2014). As Pitx3 is
not expressed in hippocampal neurons the observed cognitive
deficits are likely mediated indirectly due to degeneration
of dopaminergic projections from the mesencephalon to the
striatum and limbic structures. In contrast to toxic or lesion
models of PD the aphakia mice show a rather selective
degeneration of dopaminergic neurons of the SNc (A9-neurons).
However, a subset of A10-neurons in the VTA express Pitx3
leading to a partial degeneration of A10 cells due to Pitx3
loss of function (van den Munckhof et al., 2003; Luk et al.,
2013). Although, embryonic neurodegeneration as observed in
aphakia mice does not reflect the natural course of Parkinson’s
disease, this genetic model has major advantages over toxic
or lesion models. One is that these interventional models
rather unselectively degenerate neuronal networks and are
accompanied by (per-)acute reactions that affect the neuronal
system irrespective of the dopaminergic degeneration. Therefore,
we believe that the aphakiamouse is an optimal animal model to
investigate how selective dopaminergic degeneration of mainly
A9 neurons affects neurogenesis in the adult neurogenic regions
(SVZ and SGZ).
Looking at cell proliferation in the SVZ of adult aphakiamice,
Lennington et al. found no difference compared to C57BL/6
animals that were used as controls (Lennington et al., 2011).
Neuronal tracing via intraventricular injection of WGA-FITC
revealed that the SVZ receives dopaminergic innervation from
ventrolateral VTA neurons that are mainly unaffected in Pitx3-
mutant animals. SVZ proliferation was reduced only after
additional MPTP-induced degeneration of these VTA neurons
(Lennington et al., 2011).
Whether adult hippocampal neurogenesis is affected in
aphakia mice has not been investigated so far. As one study
claimed an ongoing degeneration of VTA neurons in adult
aphakia mice (van den Munckhof et al., 2003), we hypothesized
that adult neurogenesis in the neurogenic regions is affected in
the aphakia Parkinson model in a regional and temporal (age-
dependent) manner. Therefore, we analyzed neuronal precursor
cell proliferation in the SVZ and SGZ of postnatal (3 weeks),
juvenile (8 weeks) and senescent (42 weeks) homozygote aphakia
mice and healthy littermates.
METHODS
Animal and Tissue Preparation
Two aphakia breeder pairs with a C57BL/6 background were
purchased from Jackson Laboratory. Homozygous Pitx3-mutant
mice (aphakia, ak/ak) and healthy controls (wild-type, WT) were
obtained by breeding heterozygous (ak/0) mice.
For the proliferation experiments (sacrificed 24 h after the
last BrdU-injection) animals were selected as follows: 4 aphakia
(1 female, 3 male) and 6 wild type mice (3 female, 3 male)
at the age of 3 weeks, 7 aphakia and 7 wild type (4 female, 3
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male in each group; for BrdU-quantification only female animals
were taken into account) at the age of 8 weeks and 4 aphakia
and 6 wild type at the age of 42 weeks (all male). Another
set of 8 weeks old female aphakia and wild type mice (n = 4
per group) were selected for the “BrdU-survival experiment”
(sacrificed 4 weeks after the last BrdU-injection). Animals lived
in regular laboratory cages (3–4 animals per cage) in a 12-h
light/dark circadian rhythm and had access to food and water
ad libitum. To investigate running induced neurogenesis a subset
of 8 weeks old male aphakia and wild type mice (n = 3 per
group) had access to a running wheel or lived in regular cages
(control condition) for 7 days and were sacrificed at the end
of the running period. All Animals were weaned at postnatal
day 21. Except for breeding animals that were excluded from
the experiment, female and male mice were raised separately.
All animal experiments were in accordance with German animal
protection laws and institutionally approved by the Technische
Unviersität Dresden Animal Care and Use Committee and
authorized by the government (Regierungspräsidium Dresden.
Germany).
Correct differentiation between aphakia and healthy
littermates for experiments and breeding required genotyping.
DNA was extracted out of a small part of the tail with DNeasy kit,
Qiagen. PCR analysis was performed with two pairs of primers
to avoid binding problems at the repetitive sequences of the
promoter region. Primer pair A Forward 5′-ctctccagcctccctcaata-
3′; Reverse 5′-tgttaacgatgtggactaatggt-3′binding before and in
the deletion, pair B Forward 5′-ctacgccctcctgtcttctg-3′; Reverse
5′-ccaacctgagagaagcccta-3′covers the whole deletion.
For proliferation experiments the animals received 50 mg/kg
bodyweight of Bromodeoxyuridine (BrdU, Sigma, St. Louis,
USA) in sterile 0.9% NaCl solution once daily for three
consecutive days and were sacrificed 24 h after the last BrdU-
injection. For the “survival” experiment 8 weeks old animals were
sacrificed 4 weeks after the last BrdU-injection at the age of 12
weeks.
At the end of each experiment all mice were deeply
anesthetized with ketamine and perfused transcardially with 4%
formaldehyde in cold 0.1 M phosphate buffer. After transcardial
perfusion, brains were removed from all animals and stored in 4%
formaldehyde overnight at 4◦C. Following fixation, brains were
transferred to 30% sucrose for 72 h. After sucrose saturation,
brains were cut in the coronal plane in 40 µm thick sections
on a dry-ice-cooled copper block on a sliding microtome (Leica,
Bensheim) and stored in a cryoprotectant solution at−20◦C.
Immunohistochemistry
For BrdU detection slices were incubated in 2 N HCl for 30 min
at 37◦C prior to 30 min blocking with 5% donkey serum and
first antibody incubation over night at 4◦C. To determine the
total number of BrdU+ or TH+ cells we used the peroxidase
method (ABC system, Vectastain, Vector Laboratories) with
biotinylated donkey anti-rat or anti-rabbit antibody (1:500,
Dianova) and diaminobenzidine (DAB, Sigma) as chromogen.
The secondary antibody incubation time was 2 h. DAB-
stained sections were mounted on coated microscope slides and
cover-slipped with Neo-Mount (Merck, Darmstadt, Germany).
For immunohistochemistry including immunofluorescent triple
labeling we used the following primary antibodies: goat anti-DCX
(1:200; Santa Cruz Biotech.), rat anti-BrdU (1:250, abcam), rabbit
anti-Ki67 (1:200; abcam) rabbit anti-TH (1:300, Pel Freez). The
conjugated secondary antibodies consisted of donkey anti-rat,
anti-goat and anti-rabbit antibodies (Alexa fluor 488, 555, and
647, Invitrogen) at a dilution of 1:500.
Quantifications
For absolute cell counts series of every six section (240 µm
apart) were stained for BrdU or TH with the peroxidase method.
Positive BrdU-cells were counted by a blinded investigator
throughout the rostrocaudal extent of the granule cell layer and
SGZ of the hippocampus and the SVZ. TH+ cells were counted in
mesencephalon and spatialized to the VTA and SN by anatomical
criteria. The optical dissector method was modified as described
previously (Kempermann et al., 2003) in that cells appearing in
the uppermost focal plane, when focusing into the section, were
not counted to avoid overestimation of the absolute cell number.
Absolut cell numbers were counted in every six section of the
entire structure of interest. In adult mice the sample size (number
of sections) was 9 for the SGZ, 11 for the SVZ and 5 for the SN
and VTA. To estimate the total number of BrdU and TH-labeled
cells the resulting numbers were multiplied by 6.
To differentiate between cell numbers in the ventral and dorsal
part of the SVZ, respectively, the SVZ was virtually halved and
divided into a ventral and dorsal part.
Proportional analyses of the cell phenotype were performed in
stainings of one-of-twelve series of sections from animals of each
group. For any combination of cell phenotype (DCX+, BrdU+)
100 cells within in granule cell layer of each animal were analyzed
(400–480 cells per group) in the confocal microscope (Leica
SP5, × 40 oil objective) in sequential scanning mode for co-
expression. Double labeling was confirmed by z-series of entire
nucleus or cell in question.
Statistical Analyses
Statistical significance was determined by two-sided unpaired
t-test or 2-way analysis of variance (ANOVA) followed by
Bonferroni adjusted post-hoc t-test as appropriate. Pearson
correlation test was used for correlation analyses using SPSS
version 23 (IBM SPSS Statistics Inc., Chicago, USA). Statistical
significance was defined as p < 0.05 (two-sided). All data are
expressed as mean values± SEM.
RESULTS
Young and Old Pitx-3 Mutant Mice Show
Substantial Loss of A9 and A Moderate
Reduction of A10 Dopaminergic Neurons
Pitx-3 expression in the brain is confined to dopaminergic
neurons of the mesencephalon. Loss of Pitx-3 function results
in degeneration of these neurons during late embryonic and
presumably postnatal development (Hwang et al., 2003; Nunes
et al., 2003; van den Munckhof et al., 2003). To confirm this
degeneration and to test possible and previously described age-
related changes of dopaminergic degeneration in aphakia and
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wild-type mice, we determined the absolute number of TH+
neurons in the substantia nigra (SN) and the VTA in animals
of different ages (3, 8, 12, and 42 weeks). As the Pitx3-mutation
only affects A9 andA10 neurons, but not other catecholaminergic
TH+ neurons including the noradrenergic system (Nunes et al.,
2003), changes in TH+ cells and fibers reflect dopaminergic
depletion. Two-way ANOVA with genotype and age as fixed
factors revealed a robust effect of the genotype on the number
of TH+ neurons in both dopaminergic regions, effects of age
only in the SN region, but no interactions of age and genotype
(SN: interaction effect: p = 0.575, F = 0.7; genotype: p < 0.001,
F = 382.0 and age: p = 0.008, F = 4.7; VTA: interaction effect:
p = 0.705, F = 0.5; genotype: p < 0.001, F = 53.4 and age:
p = 0.106, F = 2.2). Already at postnatal week 3, aphakia mice
have two thirds less dopaminergic neurons in the SN and about
one third less in the VTA (Figures 1A,B). 42 weeks old wild-
type animals showed a significant reduction of TH-positive SN-
neurons compared to younger mice. However, we did not find
any other age-related changes in the number of TH-positive
neurons in both groups, indicating that neuronal degeneration
due to Pitx-3 malfunction exclusively takes place during
embryonic and possibly early postnatal (P21) development. The
selective neuronal degeneration is accompanied by a robust loss
of TH-positive terminals in the neurogenic region of the SVZ
adjacent to the striatum but there was not such an obvious
alteration in catecholaminergic innervation of the dentate
gyrus (Figure 1C) likely due to remaining TH+ noradrenergic
terminals in the hippocampus that originate from the locus
coeruleus, which is unaffected in aphakia mice.
Dopaminergic Degeneration in SN and VTA
Is Accompanied by Reduced Precursor
Cell Proliferation in Juvenile But Not
Middle Aged Mice
The number of proliferating cells in neurogenic regions (SGZ
and SVZ) of aphakia and wild-type mice of different age (3,
8, and 42 weeks) were analyzed using BrdU-labeling. Mice
received daily BrdU-injections for 3 days and were sacrificed
24 h after the last BrdU injection. Additionally, the number of
dentate gyrus newborn neurons was determined 4 weeks after
the last BrdU-injection in 12 weeks old mice (see Figure 2).
As expected wild type and aphakia mice showed a robust
age related decline in the number of proliferating cells, which
was more prominent in the SGZ than in the SVZ: Two-way
ANOVA with genotype and age as fixed factors for the SGZ
revealed that genotype and age have a significant interaction
effect on proliferating cell numbers (p < 0.001, F = 20.3) and
significant differences among genotypes (p < 0.001, F = 35.6)
and age groups (p < 0.001, F = 1267.1). Similar results were
obtained for the SVZ: Significant genotype∗age interaction effect
on proliferating cell numbers (p= 0.021, F= 4.6) and significant
differences among genotypes (p = 0.001, F = 14.7) and age
groups (p < 0.001, F = 61.3). Pair-wise comparison of the
FIGURE 1 | Number of TH+ cells in the SN (A) and VTA (B) of aphakia (ak/ak) and wild-type mice (WT) at 3 weeks (3w), 8 weeks (8w), 12 weeks (12w), and 42 weeks
(42w) of age (bars indicate mean values ± SEM; *p < 0.05; **p < 0.01; ***p < 0.001 from Bonferroni-adjusted post-hoc t-test; n = 4–7). (C) TH-staining of the SN
(A9) and VTA (A10) in the mesencephalon shows the preferential degeneration of A9 neurons with a consecutive loss of dopaminergic projection to the dorsal striatum
and adjacent SVZ in aphakia mice, while the faint dopaminergic innervation of the dentate gyrus seems to be unaffected (scale bars = 200µm).
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FIGURE 2 | Number of proliferating cells indicated by BrdU-labeling (A) in the dentate gyrus (DG) and (B) in the subventricular zone (SVZ) of 3 weeks (3w), 8 weeks
(8w), and 42 weeks (42w) old aphakia (ak/ak) and wild-type mice (WT). (C) BrdU-staining of the DG and SVZ of 3 weeks old aphakia and WT mice. (D) Number
BrdU-labeled cells 4 weeks after BrdU-injection in 12 weeks old animals. (E) Ratio of BrdU+ cells 1 day after the last BrdU injection expressing neuronal precursor
marker DCX. (bars indicate mean values ± SEM; *p < 0.05; **p < 0.01; ***p < 0.001 from Bonferroni-adjusted post-hoc t-test; n = 4–6). (F) Representative
BrdU/DCX immunofluorescent staining of the denate gyrus.
two genotypes for each age group revealed that in 3 weeks old
aphakiamice the number of proliferating BrdU-labeled cells was
decreased by 18% in the SGZ (p < 0.001, Bonferroni-adjusted
post-hoc t-test) and 26% in the SVZ (p = 0.001) compared
to wild-type littermates. At postnatal week 8 we observed a
reduction of 18% less proliferating cells in the SGZ of aphakia
mice (p = 0.023) as well as in the SVZ (25%, p = 0.017).
The impairment of dentate gyrus cell proliferation in 8 weeks
old aphakia mice results in an even greater decline in the
number of newborn cells 4 weeks after the BrdU-injection [33%,
t(6) = −3.6, p = 0.011, Figure 2D]. Co-labeling with neuronal
precursor cell marker DCX 1 day after BrdU-injection revealed
no changes in the phenotype of proliferating cells (Figure 2E).
We found no differences in the number of proliferating cells
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either in the SGZ (p = 0.657) or in the SVZ (p = 0.925) of 42
weeks old animals. Taken together, dopamine depletion seems
to affect postnatal and juvenile neurogenesis, but not late adult
neurogenesis.
Since the dorsal SVZ mainly receives dopaminergic
innervation from the SN and the ventral SVZ from VTA
neurons, one could expect regional differences in SVZ
proliferation in young aphakia mice (3 weeks) due to the
heterogenic degeneration of VTA and SN neurons. However, we
did not find relevant differences in the reduction of BrdU-labeled
cells in these subregions [ventral SVZ: −28.4%, t(7) = −3.9,
p < 0.01; dorsal SVZ:−23.2%, t(7) =−3.2, p < 0.01].
Amount of Cell Proliferation in Neurogenic
Regions Correlates with the Number of SN
and VTA Dopaminergic Neurons in a
Topographic and Age Dependent Manner
To confirm the hypothesis that regional dopamine depletion
affects cell proliferation in the neurogenic regions, we looked
at the correlation of dopaminergic (TH-positive) neurons
and proliferating cells (BrdU-labeled). There is no correlation
between the number of VTAdopaminergic neurons and newborn
cells in the SGZ, neither in young nor in old animals (data not
shown). However, we found a significant correlation of VTA
dopaminergic neurons to BrdU-labeled cells in the ventral SVZ
(p = 0.028, r = 0.723) and total SVZ (p = 0.049, r = 0.669)
but not in dorsal SVZ (p = 0.104) exclusively in 3 weeks old
animals (Figure 3). The number of SN dopaminergic neurons
highly correlates with the number of proliferating cells in the
SGZ (p = 0.009; r = 0.768) and SVZ (p = 0.001; r = 0.901)
of 3 weeks old animals but not in the middle aged brain of
42 weeks old aphakia and wild type mice (p = 0.960 for SVZ;
p = 0.201 for SGZ). These observations support the assumption
that mainly A9-neurons in the SN affect the mitotic activity of
adult neural precursor cells only during postnatal development,
but not in the aging brain. Thus, loss of VTA neurons that sends
dopaminergic projections to the ventral striatum, mainly affects
cell proliferation in the ventral SVZ of young animals.
Stimulation of Precursor Proliferation by
Physical Activity Is Not Affected in
Pitx3-Mutant Mice
The number of newborn neurons in the adult brain is subject
to various behavioral and environmental factors. One of these is
physical activity leading to an increased number of proliferating
cells, mainly type-2 and 3 cells and stimulates their progression
in the precursor lineage in the adult dentate gyrus (van Praag
et al., 1999b; Kronenberg et al., 2003; Brandt et al., 2010). The
exact mechanisms that are responsible for this pro-neurogenic
FIGURE 3 | Scatter diagram depicting the number of BrdU-labeled cells in the SGZ (red) and SVZ (green) plotted against the number of TH+ cells in the SN in 3
weeks old animals (A) and 42 weeks old animals (B). (C) Number of BrdU-labeled cells in the dorsal SVZ (black square) and ventral SVZ (circle) plotted against the
number of TH+ cells in the VTA of 3 weeks old aphakia and WT mice. (D) Schematic illustration of the degeneration of dopaminergic projection to the neurogenic
regions in young and old aphakia and WT mice.
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effect of physical activity are not fully understood (Fischer et al.,
2014; Overall et al., 2016). As physical exercise has been shown
to alter dopaminergic transmission and to improve cognitive
function in animal models of PD as well as PD patients (Tanaka
et al., 2009; Petzinger et al., 2013; Klein et al., 2016), we
wanted to know whether physical activity also stimulates adult
hippocampal neurogenesis in aphakiamice that lack the majority
of dopaminergic A9 neurons. As described above, at the age of
8 weeks aphakia mice show a decreased number of proliferating
cells in the SGZ. Giving these mice the opportunity to enhance
their physical activity in a running wheel almost doubles the
number of SGZ cells expressing the cell cycle marker Ki67
(p ≤ 0.05, Figure 4). There was no statistical difference between
these aphakia and wild type mice after seven days of physical
activity indicating that runningmight rescue the reduced baseline
cell proliferation in young aphakiamice (Figure 4).
DISCUSSION
Although, Parkinson’s disease (PD) is primarily a movement
disorder, most patients also suffer from non-motor symptoms
such as depression, cognitive impairment and hyposmia during
the natural course of the disease. While the movement disorder
is a consequence of nigrostriatal neurodegeneration, it is not
clear whether the dopaminergic deficit is also responsible for
non-motor symptoms. Structural changes in the hippocampus
including reduced cellular plasticity (adult neurogenesis) due to
dopamine depletion have been suggested to impair hippocampal
FIGURE 4 | Number of cells in the SGZ of the dentate gyrus expressing the
proliferation marker Ki67 in wild-type (WT) and aphakia (ak/ak) mice under
control conditions (CTR) and after seven days of voluntary exercise in a running
wheel (RUN; bars indicate mean values ± SEM). Two-way ANOVA with
post-hoc t-test and Bonferroni adjustment with genotype and runner group as
fixed factors revealed that genotype and runner group have nosignificant
interaction effect on Ki67-positive cell numbers (p = 0.881, F = 0.02) and no
significant differences among genotypes (p = 0.160, F = 2.4), but significant
differences between runners and controls (p = 0.002, F = 19.7); *p < 0.05
from Bonferroni-adjusted post-hoc t-test; n = 3).
function and promote depression and cognitive decline in PD
(Hoglinger et al., 2004; Marxreiter et al., 2009; Takamura et al.,
2014; Klein et al., 2016; Schlachetzki et al., 2016).
Although, toxic models are widely used as animal models of
PD, there are several side effects to consider especially in the
context of adult neurogenesis, which represents a very sensitive
physiological event. It has been shown that neuronal precursor
cells of the SVZ are more vulnerable to MPTP than midbrain
dopaminergic cells indicating that dopamine depletion is not
the primary reason of impaired adult neurogenesis, at least in
the MPTP-model (He et al., 2008). Moreover, toxic or lesion
induced dopamine depletion are likely accompanied by acute
neuroimmunological reactions that might affect neural stem and
precursor cells independently of Parkinson-related degeneration.
Therefore, we looked for a non-toxic more specific model, which
is characterized by the selective degeneration of SN dopaminergic
neurons. Aphakiamice carry a mutation in the Pitx3 gene, which
also seems to play a role in human susceptibility to PD (Fuchs
et al., 2009).
As aphakiamice are visually impaired due to microphthalmia
and lack of lenses, one could argue that adult neurogenesis
alterations might be a consequence of this handicap. Due to the
lack of an appropriate control group there are only theoretical
considerations that argue against this limitation. In mice, eye-
opening occurs about 2 weeks after birth and the development of
mature visual cortex activity takes another 1–2 weeks (Rochefort
et al., 2009), indicating that relevant differences in visual function
between aphakia and wild type mice should not occur before
3–4 weeks after birth. However, in our study we found the
largest impact on adult precursor cell proliferation in 3 weeks old
mice. There was a significant correlation between dopaminergic
degeneration and BrdU+ cells, but adult neurogenesis alterations
did not seem to follow the time course of the development of
the visual system. Thus, we suggest that in this animal model,
dopaminergic depletion has a much greater regulatory impact on
adult neurogenesis than visual impairment.
Previous studies had undoubtedly demonstrated a marked
reduction of dopaminergic neurons in the SN of aphakia mice
due to late embryonic degeneration starting after E13, but
presented contradictory results concerning the involvement of
the VTA (Hwang et al., 2003; Nunes et al., 2003; van den
Munckhof et al., 2003; Smidt et al., 2004). Possible reasons
for this divergence might be methodological (e.g., estimation
of absolute cell numbers or cell density, retrograde labeling,
different anatomical classification and different age of animals).
We decided to quantify the absolute cell numbers of TH-
positive neurons in the SN and VTA defined by anatomical
criteria as early as postnatal day 21 up to 42 weeks old mice.
While the majority of TH+ fibers in the striatum originate
from dopaminergic cells (A9 and A10), the hippocampus
also receives TH+ noradrenergic projections from the locus
coeruleus. However, the Pitx3-mutation in aphakiamice remains
the locus coeruleus intact (Nunes et al., 2003), thus alterations
of hippocampal neurogenesis in aphakia mice are independent
of the noradrenergic system. Here we show a reduction of TH-
cells in the SN of aphakiamice to 35% of wild-type mice and 65%
of the control-level in the VTA. Except for a slight reduction in
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SN dopaminergic cells in 42 weeks old wild type mice there was
no further age-dependent change in the number of TH-positive
cells in both regions. As Pitx3 is not exclusively expressed in SN
neurons but also in a subset of VTA neurons, it is likely that
the same mechanism that lead to degeneration of A9-neurons in
late embryonic development also affects a subset of A10-neurons
of the VTA. However, the different extent of neurodegeneration
in mesencephalic subregions make the aphakia mouse a
perfect model to investigate PD and how dopamine depletion
might affect adult neurogenesis: (i) The degeneration pattern
is very similar to that of PD patients (Smidt et al., 1997;
Jellinger, 2001); and (ii) due to the selective degeneration of
topographically organized dopaminergic neurons one would
expect that the neurogenic regions are unequally affected by the
loss of dopaminergic innervation. The majority of dopaminergic
projections from the mesencephalon terminate in the striatum,
of which the dorsal part is innervated by the SN and the ventral
part by the VTA. Accordingly the dorsal and ventral part of the
SVZ receives dopaminergic input from the same topographic
regions (Lennington et al., 2011; Hoglinger et al., 2014). Both the
SN and VTA homogenously innervate the SGZ of the dentate
gyrus (Hoglinger et al., 2014). In our experiment we found a
reduced cell proliferation in the SVZ of 3 weeks old mice, but no
significant differences in the reduction of ventral or dorsal SVZ
proliferation. However, the extent of dopaminergic denervation
correlates with the degree of precursor cell reduction. Focusing
on the number of TH-cells in the VTA (A10) and how this
correlates with the amount of BrdU-cells in the dorsal and
ventral SVZ at postnatal day 21 revealed a significant correlation
only for the ventral part but not the dorsal SVZ. Whereas,
reduced proliferation rate in the dorsal SVZ highly correlates
with the extent of dopaminergic degeneration of SN neurons
(A9). This data underlines how the degeneration of SN and
VTA differentially affects precursor cell proliferation in the dorsal
and ventral SVZ. As aphakia mice show a degeneration of both,
A9 and A10 neurons, there might no relevant difference in the
reduction of BrdU-cells between ventral and dorsal part of the
SVZ, but a region-specific correlation. In contrast, the dentate
gyrus receives dopaminergic input from both regions (VTA and
SN), but a significant correlation could only be demonstrated
for the number of SN dopaminergic neurons and BrdU-cells
in the DG, likely due to the more prominent degeneration
of the SN compared to the VTA in aphakia mice. Further
experiments with absolute selective degeneration of A9 and A10
neuron, respectively, are required to clarify the distinct role of
dopaminergic projections for adult neurogenic sub-regions.
Interestingly, we found the most distinct reduction of BrdU-
labeled cells in the dentate gyrus of young adult animals
4 weeks after BrdU-injection reflecting newborn but already
differentiated granule cells. The number of newborn neurons that
are functionally integrated into the existing network is regulated
by two key events. The first one is cell proliferation, which results
in a peak of BrdU-labeled cells during the first 2 days after
BrdU injection (Kronenberg et al., 2003; Kempermann et al.,
2004; Steiner et al., 2004). The second is the selection of about
two thirds of precursor cells and immature neurons during the
following days and weeks (Brandt et al., 2003; Kempermann
et al., 2004). Proliferation (1 day after last BrdU-injection) in
the SGZ of 8 weeks old aphakia mice was slightly reduced by
18%, but amount of BrdU+ cells 4 weeks after last BrdU-injection
decreased by 33%. As a substantial number of BrdU-labeled
cells are already postmitotic 1 day after daily BrdU-injection
for 3 consecutive days (Brandt et al., 2003, 2012; Encinas et al.,
2011), we do not believe that the major reduction during the
following 4 weeks is due to decreased proliferation. We rather
suggest that dopamine also regulates the selection and survival
of newborn neurons. This is in accordance with reports that D1-
like receptor activation promotes survival of newborn cells in the
adult hippocampus (Takamura et al., 2014).
Although, there is no age dependent change in the
dopaminergic degeneration of aphakiamice, the initial reduction
of cell proliferation in the neurogenic regions in young animals is
not further detectable in middle-aged mice. This finding implies
that regulatory influence on neurogenic regions by dopaminergic
projections diminishes with ageing. A compensatory structural
change in aphakia mice rescuing dopamine deficit in the SVZ
and SGZ are unlikely, because tracing studies in this mouse
strain failed to detect any changes in dopaminergic projections
to the SVZ (Lennington et al., 2011). We suggest that age-
dependent structural changes of the neurogenic niches are
responsible for the attenuation of dopaminergic precursor cell
regulation in older animals. Hippocampal dopamine receptor
density is reduced in aging animals and humans (Amenta et al.,
2001; Hemby et al., 2003). Moreover, aging is associated with
a reduction of adult neural stem and precursor cells. This age-
related decline does not uniformly affect all cell populations,
but preferentially transiently amplifying highly proliferative
precursor cells, which is the cell source that expresses dopamine
receptors and can thereby be stimulated by dopamine (Hoglinger
et al., 2004; Lao et al., 2013). Dopaminergic treatment using the
dopamine agonist pramipexole increased SGZ cell proliferation
in 12 weeks old wild type mice (Salvi et al., 2016), but has
no effect on adult hippocampal neurogenesis in 46 weeks
old healthy mice (Chiu et al., 2015). Different study designs
do not allow a direct comparison of these two observations,
but these findings underline the age-dependent sensitivity to
dopamine as a regulator of adult precursor cell proliferation.
Similar age dependent effects had been found for fluoxetine, a
selective serotonin reuptake inhibitor, known to increase adult
hippocampal neurogenesis in young animals but fail to do so
in elderly mice (Couillard-Despres et al., 2009). As non-motor
symptoms has also been shown in aphakia mice (Ardayfio et al.,
2008), our results indicate that at least in old animals this deficits
are not solely attributed to changes in adult neurogenesis.
Physical exercise is a robust stimulator of adult hippocampal
precursor proliferation resulting in an increased number of
new granule cells and better learning performance in mice
(van Praag et al., 1999a,b). Physical training also improves
cognitive and motor functions in PD patients (Tanaka et al.,
2009; Petzinger et al., 2013). Young aphakia mice (8 weeks) that
had less proliferating cells in the SGZ of the DG under control
conditions doubled the number of proliferating cells after 1 week
of physical exercise (voluntary wheel running). Despite of the
dramatic depletion of midbrain dopaminergic neurons, these
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mice respond to the stimulus in the same way as wild-type mice.
Thus, running induced cell proliferation seems to be independent
of dopaminergic degeneration, which has further implications
for adjuvant non-pharmacological treatment strategies of non-
motor symptoms in PD.
Together, the Pitx3-mutant animal model of PD is
characterized by a moderate reduction of precursor cell
proliferation in the SGZ and SVZ only in young animals (3–8
weeks) while precursor cell proliferation in older animals and
stimulation of hippocampal neurogenesis remain unaffected.
Although, this genetic animal model does not reflect the natural
course of PD, as the dopaminergic depletion already starts
during embryonic development, it gives us the opportunity
to investigate adult neurogenesis after PD-like selective
degeneration of the nigrostriatal and—to a lesser degree—the
mesolimbic system and independently of any toxic or lesion
induced side effects. Recent studies using genetic animal
models of PD (like α-synuclein overexpression) confirmed
an impairment of adult neurogenesis (Marxreiter et al.,
2009, 2013a; Kohl et al., 2016; Schlachetzki et al., 2016).
Whether α-synuclein expression is directly involved in this
impairment or rather reduces neurogenesis as a consequence
of dopaminergic or even serotonergic degeneration is still
being debated. However, most of these studies investigated
adult neurogenesis in young (around 8 weeks old) animals,
which we suggest are more susceptible to dopaminergic
depletion than the brains of older animals. As PD mainly
affects the senescent brain, future studies should take into
account that adult neurogenesis in the aging brain might behave
differently.
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